Who owns UroGen Pharma Ltd (URGN)? Superinvestor holders

2 superinvestors of the 157 tracked here hold UroGen Pharma Ltd (URGN) in their latest 13F filing, with $4.1M between them. Polen Capital team gives it the most weight: 0.02% of the reported portfolio. In their latest reported quarter, Polen Capital team added; Cathie Wood reduced.

Hold it now
2
of 157 tracked
Combined value
$4.1M
Bought / sold
1 / 1
last quarter

Key facts

Superinvestors holding it
2 of 157
Biggest holder
Cathie Wood, $2.2M
Largest weight
Polen Capital team, 0.02%of their portfolio
Combined value
$4.1M
Bought last quarter
1
Sold last quarter
1

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding URGN, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Polen Capital teamPolen Capital Management0.02%$1.9M46.8K▲ Added 58%+17.19KQ3 2026
2Cathie WoodARK Invest0.01%$2.2M54.25K▼ Reduced 47%−47.27KQ3 2026

Quarter by quarter

Superinvestor ownership of URGN by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 2026922101.05K$4.1M11
Q2 20261571101.51K$3.7M01
Q1 20261572126.55K$2.3M01
Q4 20251572132.48K$3.1M01
Q3 20251572137.72K$2.7M11
Q2 20251571166.09K$2.3M02
Q1 202515623.39M$37.5M20
Q4 20241560——00

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of URGN held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Cathie Wood54.25K101.51K115.55K121.48K126.72K166.09K185.79K—
Polen Capital team46.8K———————
Andrew Spokes——11K11K11K———
Peter Kolchinsky·—————3.21M—

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own URGN?

In their latest 13F filings: Polen Capital team (0.02% of the portfolio, $1.9M), Cathie Wood (0.01% of the portfolio, $2.2M).

Who bought URGN last quarter?

Polen Capital team (added 58%). “Last quarter” is each investor's latest reported quarter.

Who sold URGN last quarter?

Reduced: Cathie Wood (47% fewer shares).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns UroGen Pharma Ltd (URGN)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/URGN/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to URGN by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.